Combined use of Galderma’s SOOLANTRA (ivermectin1% Cream) and Mirvaso (Brimonidine 0.33% Gel) pack a one-two punch against the erythema and inflammatory lesions of rosacea, the MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea (MOSAIC) study shows.
“Concomitant administration of IVM cream with BR gel demonstrated good efficacy and safety, endorsing the comprehensive approach to this complex disease,” the study authors conclude. “Early introduction of BR, along with a complete daily skin care regimen may accelerate treatment success without impairing tolerability.”
The findings appear in the Journal of Drugs in Dermatology.
"This is the first study evaluating the benefit of using both ivermectin 1% and brimonidine 0.33% in combination to effectively target the multiple features of rosacea," says study author Linda Stein Gold, a dermatologist at Henry Ford Hospital in Detroit, MI, in a news release. "This study develops a comprehensive and early treatment approach to this complex disease."